Table 16 ACT—AntiXa concordance analysis by Kappa coefficient study for the first 5 days of ECMO

ACT

192

196

194

196

194

Median [IC95%]

[181 to 200]

[191 to 204]

[186 to 201]

[183 to 210]

[187 to 207]

Anti Xa

0.21

0.25

0.18

0.21

0.21

Median [IC95%]

[0.17 to 0.34]

[0.20 to 0.32]

[0.14 to 0.23]

[0.17 to 0.25]

[0.16 to 0.24]

Kappa

0.085

0.082

0.069

−0.238

0.115

[IC95%]

[−0.149 to 0.320]

[−0.150 to 0.315]

[0.172 to 0.310]

[−0.530 to 0.054]

[−0.189 to 0.419]

Evening

ACT

195

193

195

196

195

Median [IC95%]

[190 to 205]

[188 to 200]

[189 to 197]

[185 to 204]

[180 to 199]

Anti Xa

0.23

0.19

0.17

0.22

0.19

Median [IC95%]

[0.21 to 0.30]

[0.13 to 0.26]

[0.13 to 0.21]

[0.19 to 0.26]

[0.14 to 0.25]

Kappa

0.034

0.093

0.154

0.208

0.062

[IC95%]

[−0.198 to 0.267]

[−0.113 to 0.301]

[−0.075 to 0.383]

[−0.093 to 0.509]

[−0.283 to 0.408]